Literature DB >> 32435984

Exceeding a "critical" muscle Pi: implications for [Formula: see text] and metabolite slow components, muscle fatigue and the power-duration relationship.

Bernard Korzeniewski1, Harry B Rossiter2,3.   

Abstract

PURPOSE: The consequences of the assumption that the additional ATP usage, underlying the slow component of oxygen consumption ([Formula: see text]) and metabolite on-kinetics, starts when cytosolic inorganic phosphate (Pi) exceeds a certain "critical" Pi concentration, and muscle work terminates because of fatigue when Pi exceeds a certain, higher, "peak" Pi concentration are investigated.
METHODS: A previously developed computer model of the myocyte bioenergetic system is used.
RESULTS: Simulated time courses of muscle [Formula: see text], cytosolic ADP, pH, PCr and Pi at various ATP usage activities agreed well with experimental data. Computer simulations resulted in a hyperbolic power-duration relationship, with critical power (CP) as an asymptote. CP was increased, and phase II [Formula: see text] on-kinetics was accelerated, by progressive increase in oxygen tension (hyperoxia).
CONCLUSIONS: Pi is a major factor responsible for the slow component of the [Formula: see text] and metabolite on-kinetics, fatigue-related muscle work termination and hyperbolic power-duration relationship. The successful generation of experimental system properties suggests that the additional ATP usage, underlying the slow component, indeed starts when cytosolic Pi exceeds a "critical" Pi concentration, and muscle work terminates when Pi exceeds a "peak" Pi concentration. The contribution of other factors, such as cytosolic acidification, or glycogen depletion and central fatigue should not be excluded. Thus, a detailed quantitative unifying mechanism underlying various phenomena related to skeletal muscle fatigue and exercise tolerance is offered that was absent in the literature. This mechanism is driven by reciprocal stimulation of Pi increase and additional ATP usage when "critical" Pi is exceeded.

Entities:  

Keywords:  Computer model; Critical power; Exercise duration; Power output; on-kinetics

Mesh:

Year:  2020        PMID: 32435984     DOI: 10.1007/s00421-020-04388-4

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  8 in total

1.  Bioenergetic Mechanisms Linking V˙O2 Kinetics and Exercise Tolerance.

Authors:  Richie P Goulding; Harry B Rossiter; Simon Marwood; Carrie Ferguson
Journal:  Exerc Sport Sci Rev       Date:  2021-10-01       Impact factor: 6.642

2.  Insights into neuromuscular fatigue using 31 P-MRS.

Authors:  Sean C Forbes
Journal:  J Physiol       Date:  2022-06-10       Impact factor: 6.228

3.  On the role of skeletal muscle acidosis and inorganic phosphates as determinants of central and peripheral fatigue: A 31 P-MRS study.

Authors:  Thomas J Hureau; Ryan M Broxterman; Joshua C Weavil; Matthew T Lewis; Gwenael Layec; Markus Amann
Journal:  J Physiol       Date:  2022-06-02       Impact factor: 6.228

4.  Factors determining training-induced changes in V̇O2max, critical power, and V̇O2 on-kinetics in skeletal muscle.

Authors:  Bernard Korzeniewski; Harry B Rossiter
Journal:  J Appl Physiol (1985)       Date:  2020-11-19

5.  Response.

Authors:  Richie P Goulding; Harry B Rossiter; Simon Marwood; Carrie Ferguson
Journal:  Exerc Sport Sci Rev       Date:  2022-04-01       Impact factor: 6.642

6.  The impact of a single surfing paddling cycle on fatigue and energy cost.

Authors:  Márcio Borgonovo-Santos; Rodrigo Zacca; Ricardo J Fernandes; João Paulo Vilas-Boas
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

Review 7.  Power profiling and the power-duration relationship in cycling: a narrative review.

Authors:  Peter Leo; James Spragg; Tim Podlogar; Justin S Lawley; Iñigo Mujika
Journal:  Eur J Appl Physiol       Date:  2021-10-27       Impact factor: 3.078

8.  Skeletal muscle biochemical origin of exercise intensity domains and their relation to whole-body V̇O2 kinetics.

Authors:  Bernard Korzeniewski; Harry B Rossiter
Journal:  Biosci Rep       Date:  2022-08-31       Impact factor: 3.976

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.